Revolution Medicines (RVMD) Other Gross PP&E Adjustments: 2019-2025
Historic Other Gross PP&E Adjustments for Revolution Medicines (RVMD) over the last 6 years, with Sep 2025 value amounting to -$76.9 million.
- Revolution Medicines' Other Gross PP&E Adjustments fell 153.62% to -$76.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$276.4 million, marking a year-over-year decrease of 91.15%. This contributed to the annual value of -$73.0 million for FY2024, which is 57.21% down from last year.
- As of Q3 2025, Revolution Medicines' Other Gross PP&E Adjustments stood at -$76.9 million, which was down 30.64% from -$58.8 million recorded in Q2 2025.
- In the past 5 years, Revolution Medicines' Other Gross PP&E Adjustments ranged from a high of $8.4 million in Q1 2023 and a low of -$76.9 million during Q3 2025.
- For the 3-year period, Revolution Medicines' Other Gross PP&E Adjustments averaged around -$40.7 million, with its median value being -$35.7 million (2024).
- In the last 5 years, Revolution Medicines' Other Gross PP&E Adjustments spiked by 124.02% in 2023 and then tumbled by 524.42% in 2024.
- Revolution Medicines' Other Gross PP&E Adjustments (Quarterly) stood at -$41.2 million in 2021, then rose by 29.57% to -$29.0 million in 2022, then tumbled by 60.26% to -$46.5 million in 2023, then tumbled by 57.21% to -$73.0 million in 2024, then tumbled by 153.62% to -$76.9 million in 2025.
- Its Other Gross PP&E Adjustments was -$76.9 million in Q3 2025, compared to -$58.8 million in Q2 2025 and -$67.7 million in Q1 2025.